Expression of cell cycle regulatory proteins in ovaries prophylactically removed from Jewish Ashkenazi BRCA1 and BRCA2 mutation carriers: Correlation with histopathology

Gynecologic Oncology

Volumn 99, Issue 2, 2005, Pages 367-375

  Kerner, Ram ^a   Sabo, Edmond ^b   Gershoni Baruch, Ruth ^c   Beck, Dan ^c   Ben Izhak, Ofer ^c  

^a RABIN MEDICAL CENTER   (Israel)

^b RHODE ISLAND HOSPITAL   (United States)

^c RAMBAM MEDICAL CENTER   (Israel)

Author keywords

BRCA; Cell cycle regulatory proteins; Jewish Ashkenazi women; Prophylactic oophorectomy

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; CELL CYCLE PROTEIN; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P16; PROTEIN P16INK4A; PROTEIN P27; PROTEIN P53; S PHASE KINASE ASSOCIATED PROTEIN 2;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BENIGN TUMOR; CANCER PREVENTION; CANCER RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; EPITHELIUM; FEMALE; GENE MUTATION; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JEW; OCCULT CANCER; OVARIECTOMY; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; JEWS; MIDDLE AGED; OVARIAN NEOPLASMS; OVARY; PRECANCEROUS CONDITIONS;

EID: 27144524254     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.06.041     Document Type: Article

References (49)

1. K. Leeper, R. Garcia, E. Swisher, B. Goff, B. Greer, and P. Paley Pathologic findings in prophylactic oophorectomy specimens in high-risk women Gynecol. Oncol. 87 2002 52 56
2. L. Resta, S. Russo, G.A. Colucci, and J. Prat Morphologic precursors of ovarian epithelial tumors Obstet. Gynecol. 82 1993 181 186
3. H. Salazar, A.K. Godwin, and M.B. Daly Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies J. Natl. Cancer Inst. 88 1996 1810 1820
4. L. Deligdisch, A.J. Einstein, D. Guera, and J. Gil Ovarian dysplasia in epithelial inclusion cysts. A morphometric approach using neural networks Cancer 76 1995 1027 1034
5. P.W. Schlosshauer, C.J. Cohen, and F. Penault-Llorca Prophylactic oophorectomy: a morphologic and immunohistochemical study Cancer 98 2003 2599 2606
6. S.N. Agoff, J.E. Mendelin, V.S. Grieco, and R.L. Garcia Unexpected gynecologic neoplasms in patients with proven or suspected BRCA-1 or -2 mutations: implications for gross examination, cytology, and clinical follow-up Am. J. Surg. Pathol. 26 2002 171 178
7. T.J. Colgan, J. Murphy, D.E. Cole, S. Narod, and B. Rosen Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status Am. J. Surg. Pathol. 25 2001 1283 1289
8. R.R. Barakat, M.G. Federici, P.E. Saigo, M.E. Robson, K. Offit, and J. Boyd Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes Cancer 89 2000 383 390
9. J.M. Piek, R.H. Verheijen, and F.H. Menko Expression of differentiation and proliferation related proteins in epithelium of prophylactically removed ovaries from women with a hereditary female adnexal cancer predisposition Histopathology 43 2003 26 32
10. B.A. Werness, A.M. Afify, G.H. Eltabbakh, K. Huelsman, M.S. Piver, and J.M. Paterson p53, c-erbB, and Ki-67 expression in ovaries removed prophylactically from women with a family history of ovarian cancer Int. J. Gynecol. Pathol. 18 1999 338 343
11. M.J. Casey, C. Bewtra, L.L. Hoehne, A.D. Tatpati, H.T. Lynch, and P. Watson Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds Gynecol. Oncol. 78 2000 278 287
12. B.A. Werness, A.M. Afify, K.L. Bielat, G.H. Eltabbakh, M.S. Piver, and J.M. Paterson Altered surface and cyst epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer Hum. Pathol. 30 1999 151 157
13. K.M. Feeley, and M. Wells Precursor lesions of ovarian epithelial malignancy Histopathology 38 2001 87 95
14. A.S. Wong, P.C. Leung, S.L. Maines-Bandiera, and N. Auersperg Metaplastic changes in cultured human ovarian surface epithelium In Vitro Cell Dev. Biol. Anim. 34 1998 668 670
15. R.E. Scully Early de novo ovarian cancer and cancer developing in benign ovarian lesions Int. J. Gynaecol. Obstet. 49 1995 S9 S15 [Suppl]
16. M.F. Fathalla Incessant ovulation-A factor in ovarian neoplasia? Lancet 2 1971 163
17. R. Hutson, J. Ramsdale, and M. Wells p53 protein expression in putative precursor lesions of epithelial ovarian cancer Histopathology 27 1995 367 371
18. D. Hershko, G. Bornstein, and O. Ben-Izhak Inverse relation between levels of p27(Kip1) and of its ubiquitin ligase subunit Skp2 in colorectal carcinomas Cancer 91 2001 1745 1751
19. E.W. Newcomb, M. Sosnow, R.I. Demopoulos, A. Zeleniuch-Jacquotte, J. Sorich, and J.L. Speyer Expression of the cell cycle inhibitor p27KIP1 is a new prognostic marker associated with survival in epithelial ovarian tumors Am. J. Pathol. 154 1999 119 125
20. O. Ben-Izhak, S. Lahav-Baratz, and S. Meretyk Inverse relationship between Skp2 ubiquitin ligase and the cyclin dependent kinase inhibitor p27Kip1 in prostate cancer J. Urol. 170 2003 241 245
21. J.T. Keating, A. Cviko, and S. Riethdorf Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia Am. J. Surg. Pathol. 25 2001 884 891
22. R. Klaes, T. Friedrich, and D. Spitkovsky Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri Int. J. Cancer 92 2001 276 284
23. M.S. Steiner, Y. Wang, Y. Zhang, X. Zhang, and Y. Lu p16/MTS1/INK4A suppresses prostate cancer by both pRb dependent and independent pathways Oncogene 19 2000 1297 1306
24. M. Sasaki, K. Sugio, and Y. Kuwabara Alterations of tumor suppressor genes (Rb, p16, p27 and p53) and an increased FDG uptake in lung cancer Ann. Nucl. Med. 17 2003 189 196
25. S. Zhu, X. Wang, L. Shao, W. Chen, X. Chen, and H. Wu Quantitative study on expression of p16 multiple tumor suppressor gene in salivary gland neoplasm J. Tongji Med. Univ. 19 1999 155 157
26. A.A. Makitie, C. MacMillan, and J. Ho Loss of p16 expression has prognostic significance in human nasopharyngeal carcinoma Clin. Cancer Res. 9 2003 2177 2184
27. J.S. Ng, A.C. Han, M.I. Edelson, and N.G. Rosenblum Oncoprotein profiles of primary peritoneal malignant mixed mullerian tumors Int. J. Gynecol. Cancer 13 2003 870 874
28. J. Wang, S. Zhang, S. Wang, and F. Li A study on P16 and P53 protein expressions in ovarian serous cystadenocarcinoma HuaXi YiKe DaXue XueBao 28 423 1997 417 419
29. D.C. Huang, L.A. O'Reilly, A. Strasser, and S. Cory The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry EMBO J. 16 1997 4628 4638
30. S. Mazel, D. Burtrum, and H.T. Petrie Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death J. Exp. Med. 183 1996 2219 2226
31. S.K. Chiou, L. Rao, and E. White Bcl-2 blocks p53-dependent apoptosis Mol. Cell. Biol. 14 1994 2556 2563
32. A. Basu, and S. Haldar The relationship between BcI2, Bax and p53: consequences for cell cycle progression and cell death Mol. Hum. Reprod. 4 1998 1099 1109
33. W.Y. Chan, K.K. Cheung, and J.O. Schorge Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers Am. J. Pathol. 156 2000 409 417
34. T.B. Kaur, T. Shen, and J. Gaughan Premalignant lesions in the contralateral ovary of women with unilateral ovarian carcinoma Gynecol. Oncol. 93 2004 69 77
35. R.J. Lelle In situ determination of the Ki-67 growth fraction (Ki-67 GF) in human tumors (studies in breast cancer) Acta Histochem., Suppl. 39 1990 109 124
36. G.G. Garzetti, A. Ciavattini, and G. Goteri Ki67 antigen immunostaining (MIB 1 monoclonal antibody) in serous ovarian tumors: index of proliferative activity with prognostic significance Gynecol. Oncol. 56 1995 169 174
37. A. Berchuck, M.F. Kohler, J.R. Marks, R. Wiseman, J. Boyd, and R.C. Bast Jr. The p53 tumor suppressor gene frequently is altered in gynecologic cancers Am. J. Obstet. Gynecol. 170 1994 246 252
38. M.C. King, J.H. Marks, and J.B. Mandell Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 Science 302 2003 643 646
39. A.J. Li, and B.Y. Karlan Genetic factors in ovarian carcinoma Curr. Oncol. Rep. 3 2001 27 32
40. Y. Ben David, A. Chetrit, and G. Hirsh-Yechezkel Effect of BRCA mutations on the length of survival in epithelial ovarian tumors J. Clin. Oncol. 20 2002 463 466
41. G. Hirsh-Yechezkel, A. Chetrit, and F. Lubin Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in Israel Gynecol. Oncol. 89 2003 494 498
42. J. Boyd Molecular genetics of hereditary ovarian cancer Oncology (Huntingt.) 12 1998 399 406 [discussion 409-10, 413]
43. H.A. Risch, J.R. McLaughlin, and D.E. Cole Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer Am. J. Hum. Genet. 68 2001 700 710
44. I. Weinreb, and T.J. Colgan BRCA mutations and pathology in the female genital tract Curr. Diagn. Pathol. vol. 10 2004
45. E. Dagan, and R. Gershoni-Baruch Hereditary breast/ovarian cancer-pitfalls in genetic counseling Clin. Genet. 60 2001 310 313
46. N.D. Kauff, J.M. Satagopan, and M.E. Robson Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation N. Engl. J. Med. 346 2002 1609 1615
47. T.R. Rebbeck, H.T. Lynch, and S.L. Neuhausen Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations N. Engl. J. Med. 346 2002 1616 1622
48. K.H. Lu, J.E. Garber, and D.W. Cramer Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy J. Clin. Oncol. 18 2000 2728 2732
49. C.B. Powell, E. Kenley, and L.M. Chen Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy J. Clin. Oncol. 23 2005 127 132